Abstract
Widespread use of 7-valent pneumococcal conjugate vaccine (PCV7) in children has led to significant reduction in pneumococcal disease in children and adults. However, diseases caused by serotypes not included in PCV7 have increased. A 15-valent pneumococcal conjugate vaccine (PCV15) containing serotypes in PCV7 and 8 additional serotypes (1, 3, 5, 6A, 7F, 19A, 22F, 33F) was developed and evaluated in toddlers 12 to 15 months of age. Ninety toddlers who completed an infant series with PCV7 received a single dose of either aluminum-adjuvanted PCV15, nonadjuvanted PCV15, or PCV7. Injection-site and systemic adverse events (AEs) were collected for 14 days postvaccination and serious AEs (SAEs) were collected for 30 days postvaccination. Solicited AEs included local (pain/tenderness, swelling, nodule and redness) and systemic (fatigue, arthralgia and myalgia) AEs. Serotype-specific immunoglobulin G (IgG) and opsonophagocytic (OPA) responses were measured immediately prior and 30 days postvaccination. Incidences of local and systemic AEs were comparable across vaccine groups. The majority of reported events, regardless of vaccine received, were transient and of mild to moderate intensity. No clinically significant differences were ob...Continue Reading
References
Apr 1, 1985·Statistics in Medicine·O Miettinen, M Nurminen
Feb 26, 2000·Drugs & Aging·D S Fedson
Apr 5, 2000·The Pediatric Infectious Disease Journal·S BlackK Edwards
Oct 13, 2001·The Journal of Infectious Diseases·T WuorimaaH Käyhty
Feb 15, 2003·The Pediatric Infectious Disease Journal·Taneli PuumalainenHanna Nohynek
Jun 28, 2003·Pediatrics International : Official Journal of the Japan Pediatric Society·Güler KanraAudino Podda
Aug 25, 2005·Vaccine·Tomi K WuorimaaHelena Käyhty
Sep 9, 2006·Clinical and Vaccine Immunology : CVI·Robert L Burton, Moon H Nahm
Oct 9, 2007·The Journal of Infectious Diseases·Lauri A HicksCynthia G Whitney
Oct 14, 2008·Expert Review of Anti-infective Therapy·Michael R Jacobs
Jan 1, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sandra S RichterGary V Doern
Jan 23, 2009·Clinical and Vaccine Immunology : CVI·Rocio D MarcheseDaniel Sikkema
Mar 7, 2009·The Journal of Infectious Diseases·Shabir A MadhiPeter Adrian
Jun 13, 2009·Vaccine·Steven J JacobsenPatricia Saddier
Sep 15, 2009·Lancet·Katherine L O'BrienUNKNOWN Hib and Pneumococcal Global Burden of Disease Study Team
Dec 2, 2009·The Journal of Infectious Diseases·Tamara PilishviliUNKNOWN Active Bacterial Core Surveillance/Emerging Infections Program Network
Apr 27, 2010·Vaccine·Dorothee M KieningerUNKNOWN 006 study group
Apr 30, 2010·Clinical and Vaccine Immunology : CVI·Susanna EspositoNicola Principi
Jul 1, 2010·Pediatrics·Nicola P KleinUNKNOWN Vaccine Safety Datalink
Aug 25, 2010·Pediatrics·Sylvia H YehUNKNOWN 004 Study Group
Mar 15, 2011·Vaccine·Susan S HuangJonathan A Finkelstein
May 25, 2011·Expert Review of Vaccines·Geraldine Blanchard-Rohner, Andrew J Pollard
May 31, 2011·The Lancet Infectious Diseases·Elizabeth MillerRobert C George
Jun 22, 2011·Vaccine·David CooperKathrin U Jansen
Aug 3, 2011·Expert Review of Vaccines·Marta C Nunes, Shabir A Madhi
Oct 11, 2011·The Pediatric Infectious Disease Journal·Robert FrenckUNKNOWN 3011 Study Group
Oct 20, 2011·Vaccine·E GrimprelD A Scott
Feb 15, 2012·Vaccine·Jae-Hoon SongBernard Fritzell
Apr 24, 2012·Vaccine·Karin E M ElberseLeo M Schouls
Apr 13, 2013·Vaccine·Hung Fu TsengSteven J Jacobsen
Oct 3, 2013·PLoS Medicine·Daniel R FeikinUNKNOWN Serotype Replacement Study Group
Citations
Sep 1, 2015·British Journal of Haematology·Ernest KucharMonika Karlikowska
Mar 1, 2016·Expert Opinion on Drug Safety·Susanna Esposito, Nicola Principi
May 15, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shamez N Ladhani, Mary E Ramsay
Apr 29, 2015·Vaccine·Richard McFetridgeLuwy K Musey
Jun 2, 2016·Hospital Pediatrics·Miya E Bernson-Leung, Laura L Lehman
Sep 17, 2016·Pneumonia·Anukul T Shenoy, Carlos J Orihuela
Sep 23, 2016·Expert Review of Vaccines·Susanna Esposito, Nicola Principi
Apr 15, 2017·Expert Review of Vaccines·Robert CohenCorinne Levy
Nov 14, 2017·Expert Review of Vaccines·Michael E Pichichero
Oct 13, 2017·Expert Opinion on Biological Therapy·Nicola Principi, Susanna Esposito
Sep 12, 2015·Clinical and Vaccine Immunology : CVI·D GoldblattP C Giardina
Nov 15, 2018·Human Vaccines & Immunotherapeutics·James T PetersonLuwy K Musey
Feb 20, 2019·PloS One·James Samwel NgochoBlandina Theophil Mmbaga
Jan 7, 2020·Expert Review of Vaccines·T R ConversoL C C Leite
Mar 21, 2020·Expert Review of Vaccines·Nicolas LecrenierBruce Mungall
Aug 14, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sana S AhmedTamara Pilishvili
Jul 9, 2020·The Pediatric Infectious Disease Journal·Heather L PlattUNKNOWN V114-008 Study Group
Jan 17, 2019·Human Vaccines & Immunotherapeutics·Helen L StaceyLuwy K Musey
Jan 29, 2019·Human Vaccines & Immunotherapeutics·R RuppL Musey
Jun 25, 2019·Expert Review of Vaccines·Ron Dagan
Jan 24, 2019·Vaccines·Theano LagousiVana Spoulou
May 19, 2017·Emerging Infectious Diseases·Sopio ChochuaBernard Beall
Aug 23, 2018·Scientific Reports·Felix S DubeMark P Nicol
Oct 28, 2020·Expert Review of Vaccines·Theano LagousiVana Spoulou
Nov 17, 2020·Frontiers in Microbiology·Chi-Jung WuTsai-Ling Lauderdale
Sep 15, 2019·Molecular and Cellular Probes·Hesam DorostiYounes Ghasemi
Nov 10, 2020·Vaccine·Maile T PhillipsDaniel M Weinberger
Apr 26, 2021·Pneumonia·Eleni KoufoglouAthanasios Michos
Dec 21, 2019·Microbiology Spectrum·D E BrilesM J Crain
Jun 13, 2021·Vaccine·Ravinder KaurMichael Pichichero
Aug 4, 2021·Vaccine·R K LucindeK E Gallagher